Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Report of phase I evaluation of a STAT3 ASO for hepatocellular carcinoma

Dec. 22, 2014

Novel pan tyrosine kinase receptor inhibitor identified for the treatment of cancer

Dec. 22, 2014

Preclinical characterization of a novel dual orexin receptor antagonist

Dec. 19, 2014

Cardiac biomarkers have prognostic significance in coronary artery disease

Dec. 19, 2014

Antiangiogenic gene therapy evaluated in phase I/II glioblastoma study

Dec. 19, 2014

MicroRNAs identified as potential markers of epilepsy

Dec. 19, 2014

Promising data presented on novel drug for the treatment of pyruvate kinase deficiency

Dec. 19, 2014

Biscayne Pharmaceuticals present data on novel GHRH antagonist

Dec. 19, 2014

VPAC agonists show promising results as neuroprotectors in Parkinson's disease model

Dec. 18, 2014

Preliminary phase I/IIa data for an anticancer vaccine against multiple myeloma

Dec. 18, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...